CVS Health Corporation (CVS)

Last Closing Price: 67.46 (2025-06-13)

Company Description

CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $372.81B
Net Income (Most Recent Fiscal Year) $4.61B
PE Ratio (Current Year Earnings Estimate) 11.03
PE Ratio (Trailing 12 Months) 10.61
PEG Ratio (Long Term Growth Estimate) 0.97
Price to Sales Ratio (Trailing 12 Months) 0.23
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.11
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 7.42
Pre-Tax Margin (Trailing 12 Months) 1.90%
Net Margin (Trailing 12 Months) 1.39%
Return on Equity (Trailing 12 Months) 10.59%
Return on Assets (Trailing 12 Months) 3.17%
Current Ratio (Most Recent Fiscal Quarter) 0.82
Quick Ratio (Most Recent Fiscal Quarter) 0.63
Debt to Common Equity (Most Recent Fiscal Quarter) 0.77
Inventory Turnover (Trailing 12 Months) 12.10
Book Value per Share (Most Recent Fiscal Quarter) $60.18
Earnings per Share (Most Recent Fiscal Quarter) $2.25
Earnings per Share (Most Recent Fiscal Year) $5.42
Diluted Earnings per Share (Trailing 12 Months) $4.19
Stock
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Common Shares Outstanding 1.27B
Free Float 1.25B
Market Capitalization $85.34B
Average Volume (Last 20 Days) 6.99M
Beta (Past 60 Months) 0.56
Percentage Held By Insiders (Latest Annual Proxy Report) 1.22%
Percentage Held By Institutions (Latest 13F Reports) 80.66%
Annual Dividend (Based on Last Quarter) $2.66
Dividend Yield (Based on Last Quarter) 3.94%